Development And Characterization of Inhaled Chitosan Nanoparticles Loaded with Isoniazid
Journal Title: JOURNAL OF PHARMACEUTICAL TECHNOLOGY, RESEARCH AND MANAGEMENT - Year 2014, Vol 2, Issue 2
Abstract
The objective of our study is to load first line anti-tubercular drug, Isoniazid in chitosan Nanoparticles in order to enhance bioavailability and to reduce dose frequency. The chitosan nanoparticles containing the drug Isoniazid were prepared by the method of spontaneous emulsification. Chitosan gel containing drug is cross linked with Glutaraldehyde and nanoparticle suspension obtained was centrifuged at 5000 rpm. It was then evaluated for Drug loading, swelling index, Mucoadhesive force, Zeta potential, DLS studies, DSC studies, SEM studies, In vitro Drug release, Pharmacokinetic Studies and Stability studies.Formulation 1(F1) shows maximum Drug Loading, Swelling index and mucoadhesive force. The positive zeta value was obtained for all formulations due to positive charge of polymer used in preparation of dispersion. The DLS plot of Formulations shows that Average particle diameter are in the range of 661.8-823.8nm. The SEM study revealed that the micrographs of cross linked chitosan nanoparticles have smooth surface. The thermogram of the formulations showed the shifting of endotherm. This indicates the possible change in the release kinetics and bioavailability of the drug. In vitro drug releases was found to be maximum for formulation F6. Pharmacokinetic evaluation shows all the formulation shows first order rate release profile and release mechanism from nanoparticles is diffusion controlled. Stability studies indicated that the developed chitosan nanoparticles are physically and chemically stable and retain their pharmaceutical properties at various environmental conditions over a period of 3 months.
Authors and Affiliations
Junise V , R Saraswathi
Keywords
Related Articles
- EP ID EP596691
- DOI 10.15415/jptrm.2014.22011
- Views 130
- Downloads 0
Surfactants: Pharmaceutical and Medicinal Aspects
Surfactants are amphipathic substances with lyophobic and lyophilic groups and are critical components in pharmaceutical products. Surfactants have several uses in pharmaceuticals, i) for solubilisation of hydrophobic dr...
Development and Validation of Method for the Estimation of Telmisartan as Active Pharmaceutical Ingredient in Tablet Dosage form and Prepared Spherical Agglomerates by RP-HPLC
The Present work was designed to develop and validate an accurate, precise and rapid method for the estimation of Telmisartan as Active Pharmaceutical Ingredient (API) as well as in tablet dosage form and prepared spheri...
Ebola Hemorrhagic Fever: Recent Update On Disease Status, Current Therapies And Advances In Treatment
Swiftly growing viruses are a major intimidation to human health. Such viruses are extremely pathogenic like Ebola virus, influenza virus, HIV virus, Zika virus etc . Ebola virus, a type of Filovirus, is an extremely inf...
Analgesic Activity of some 1-Phenyl-3-aryl-5- (4-(butanoloxy) phenyl) 1H-pyrazoles
A series of analgesic activity of synthesised 1 -Phenyl-3-aryl- 5-(4-(butanoloxy) phenyl) 1H-pyrazoles were synthesized from chalcones and screened for their in vitro analgesic activity. Chalcones i.e.,1-aryl-3- (4-hydro...
Synthesis, antimicrobial evaluation and QSAR studies of p-amino benzoic acid derivatives
A series of Schiff bases (1-16) and esters (17-27) of p-amino benzoic acid (PABA) was synthesized and its in vitro antimicrobial potential was evaluated by using tube dilution method. Compound 11 was found to be most pro...